We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Boston Scientific
BSX
$64.8B
| $410M | 3.38% |
9,545,382
+5,131,591
| +116% | +$197M |
|
2
Thermo Fisher Scientific
TMO
$213B
| $317M | 2.61% |
1,081,081
+305,978
| +39% | +$84.3M |
|
|
3
Amazon
AMZN
$2.51T
| $303M | 2.49% |
3,202,440
+1,733,420
| +118% | +$161M |
|
|
4
Zoetis
ZTS
$31.3B
| $273M | 2.25% |
2,407,075
-919,152
| -28% | -$96.3M |
|
5
Teleflex
TFX
$5.81B
| $250M | 2.06% |
756,383
+159,606
| +27% | +$48.2M |
|
6
McDonald's
MCD
$187B
| $245M | 2.02% |
1,179,670
-272,290
| -19% | -$53.9M |
|
|
7
Alibaba
BABA
$273B
| $210M | 1.73% |
1,237,298
+1,102,340
| +817% | +$190M |
|
|
8
Walt Disney
DIS
$161B
| $163M | 1.34% |
1,168,468
+994,529
| +572% | +$132M |
|
|
9
GoDaddy
GDDY
$11.6B
| $132M | 1.08% |
1,878,596
+1,788,699
| +1,990% | +$135M |
|
10
eBay
EBAY
$48.5B
| $123M | 1.01% |
3,104,213
+974,814
| +46% | +$36.6M |
|
11
Fidelity National Information Services
FIS
$20.7B
| $112M | 0.92% |
910,941
+405,440
| +80% | +$47.6M |
|
12
Stellantis
STLA
$16.7B
| $99.9M | 0.82% |
7,159,497
+4,946,622
| +224% | +$71.8M |
|
13
Bright Horizons
BFAM
$3.91B
| $99.9M | 0.82% |
661,981
-43,533
| -6% | -$5.84M |
|
14
AstraZeneca
AZN
$261B
| $96.8M | 0.8% |
1,172,705
+848,612
| +262% | +$66.5M |
|
15
Intuit
INTU
$77B
| $95.7M | 0.79% |
366,164
+239,030
| +188% | +$60.7M |
|
16
Ralph Lauren
RL
$22.1B
| $87.3M | 0.72% |
768,624
+33,187
| +5% | +$3.98M |
|
17
EPAM Systems
EPAM
$4.5B
| $83.6M | 0.69% |
+482,974
| New | +$83.2M |
|
18
S&P Global
SPGI
$124B
| $74.6M | 0.61% |
327,480
+28,177
| +9% | +$6.15M |
|
19
lululemon athletica
LULU
$12.6B
| $73.8M | 0.61% |
409,638
+185,940
| +83% | +$32.3M |
|
20
Hilton Worldwide
HLT
$72.9B
| $68.8M | 0.57% |
703,910
+279,477
| +66% | +$25.4M |
|
21
Idexx Laboratories
IDXX
$42.5B
| $67.5M | 0.56% |
245,280
-15,996
| -6% | -$3.94M |
|
22
Ollie's Bargain Outlet
OLLI
$3.94B
| $66.5M | 0.55% |
763,500
+192,961
| +34% | +$18.2M |
|
23
Dollar General
DG
$25.4B
| $66.5M | 0.55% |
491,927
+125,620
| +34% | +$15.9M |
|
24
Genpact
G
$5.15B
| $64.3M | 0.53% |
1,689,255
+424,264
| +34% | +$15.4M |
|
25
Texas Roadhouse
TXRH
$12.5B
| $63.5M | 0.52% |
1,182,711
+564,897
| +91% | +$31.8M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.